DENSIGEN Trademark

Trademark Overview

On Friday, February 24, 2012, a trademark application was filed for DENSIGEN with the United States Patent and Trademark Office. The USPTO has given the DENSIGEN trademark a serial number of 79110549. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, February 24, 2022. This trademark is owned by Immune Targeting Systems (ITS); Limited. The DENSIGEN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations in the nature of immunotherapies for the treatment of viral and infectious diseases, and for the treatment of cancer; vaccines

Medical research; medical development, namely, synthesising vaccines and immunotherapies
densigen

General Information

Serial Number79110549
Word MarkDENSIGEN
Filing DateFriday, February 24, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, February 24, 2022
Registration Number4284435
Registration DateTuesday, February 5, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 20, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations in the nature of immunotherapies for the treatment of viral and infectious diseases, and for the treatment of cancer; vaccines
Goods and ServicesMedical research; medical development, namely, synthesising vaccines and immunotherapies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 6, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 6, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmune Targeting Systems (ITS) Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLondon NW1 0NH
GB
Party NameImmune Targeting Systems (ITS); Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameImmune Targeting Systems (ITS); Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Monday, September 19, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, September 19, 2022DEATH OF INTERNATIONAL REGISTRATION
Saturday, December 4, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 3, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, June 11, 2020GENERIC MADRID TRANSACTION SENT TO IB
Thursday, June 11, 2020GENERIC MADRID TRANSACTION CREATED
Wednesday, May 6, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 25, 2019NEW REPRESENTATIVE AT IB RECEIVED
Friday, September 6, 2019CANCELLED SECTION 71
Monday, February 5, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, May 25, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, May 6, 2013FINAL DISPOSITION NOTICE SENT TO IB
Monday, May 6, 2013FINAL DISPOSITION PROCESSED
Sunday, May 5, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 5, 2013REGISTERED-PRINCIPAL REGISTER
Sunday, December 23, 2012NOTIFICATION PROCESSED BY IB
Tuesday, November 20, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 20, 2012PUBLISHED FOR OPPOSITION
Wednesday, October 31, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 31, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 31, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 17, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 17, 2012ASSIGNED TO LIE
Tuesday, October 2, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 1, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 1, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 1, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 1, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 25, 2012REFUSAL PROCESSED BY IB
Thursday, June 7, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, June 7, 2012REFUSAL PROCESSED BY MPU
Thursday, June 7, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, June 6, 2012NON-FINAL ACTION WRITTEN
Wednesday, June 6, 2012ASSIGNED TO EXAMINER
Tuesday, April 17, 2012APPLICATION FILING RECEIPT MAILED
Wednesday, April 11, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 10, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

densigen treatment medical vaccines immunotherapies synthesising research development namely diseases nature